Compare Packaging Corporation of America (PKG) vs Travere Therapeutics Inc. Common Stock (TVTX) Price & Performance

Packaging Corporation of America (PKG) trades at $231.65, up 1.68% on the day, with a bearish technical signal from moving averages. The company reported mixed quarterly earnings, beating in Q1 and Q2 2026 but missing in Q4 2025, while revenue is projected to grow to $9.5B in 2026. Analyst consensus is a 'Hold' with a $272.43 price target, and the stock offers a $1.50 quarterly dividend. Recent news highlights institutional investments and upcoming Q3 earnings discussion.

PKG presents a cautious outlook with steady revenue growth offset by margin pressures, as net income is expected to decline to $692M in 2026. The primary opportunity lies in the consensus price target suggesting ~18% upside, but risks include rising costs, competitive pressures, and bearish technical trends. Investors should weigh the dividend yield against earnings volatility and valuation multiples above sector averages.

Travere Therapeutics (TVTX) trades at $51.80, down 0.42% on the day, with a neutral technical signal. The company reported strong revenue growth but persistent net losses, with a 2025 net income margin of -7.35%. Recent news includes new data presentations for its key drug FILSPARI and a CEO transition. Analyst consensus is strongly bullish with an 83.33% buy rating and a $70.60 price target, suggesting significant upside from the current price.

The outlook for TVTX hinges on the commercial success of FILSPARI, which shows promising sales growth, but profitability remains a challenge. Key risks include execution of the CEO transition, competitive pressures in nephrology treatments, and the company's ability to achieve sustained profitability. The high valuation multiples relative to negative earnings present a risk-reward balance for investors.